Nataša Čolović - Concepedia

Author

Nataša Čolović

Also Known As

N Colovic, N Colović, N. COLOVIC, N. Colovic, N. Colović, N. Čolović, N. Čolovič, N.R Čolović, Natasa Colovic, Natasa Colović

184

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

University of Belgrade Centar za Promociju Nauke University of Kragujevac Institute of Molecular Genetics and Genetic Engineering Oncology Institute of Vojvodina

NČ

About

Nataša Čolović is an author at University of Belgrade specializing in medicine, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	20	464
2	Health Sciences	4	4	83
3	Public Health	2	2	64
4	Blood Transplantation	1	1	31
5	Cell Biology	1	1	20

Nataša Čolović

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) Livio Pagano, Jon Salmanton‐García, Francesco Marchesi, Journal of Hematology & Oncology	2021	312
Association of Bax Expression and Bcl2/Bax Ratio with Clinical and Molecular Prognostic Markers in Chronic Lymphocytic Leukemia Ksenija Vučićević, Vladimir Jakovljević, Nataša Čolović, Journal of Medical Biochemistry	2016	75
Thrombotic events in acute promyelocytic leukemia Mirjana Mitrović, Nada Suvajdžić, Ivo Elezović, Thrombosis Research Hematological MalignancyThrombosisMixed-phenotype Acute LeukemiaMalignant Blood DisorderHematology	2014	68
Decreased CD161 activating and increased CD158a inhibitory receptor expression on NK cells underlies impaired NK cell cytotoxicity in patients with multiple myeloma Gordana Konjević, Ana Vuletić, Katarina Mirjačić Martinović, Journal of Clinical Pathology	2016	51
Functional Analysis of the Role of the<i>TPMT</i>Gene Promoter VNTR Polymorphism in<i>TPMT</i>Gene Transcription Branka Zukić, Milena Radmilovic, Maja Stojiljković, Pharmacogenomics	2010	40
Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemia Nataša Čolović, Nataša Tos̆ić, Sanja Aveic, Annals of Hematology Hematological MalignancyMedicineAcute Myeloid LeukemiaMixed-phenotype Acute LeukemiaHematology	2007	38
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry Jon Salmanton‐García, Francesco Marchesi, María Gomes da Silva, EClinicalMedicine Covid-19 PandemicHaematological MalignanciesAntiviral TherapyVirologyEpicovideha Registry	2023	33
Mycophenolate mophetil therapy for chronic immune thrombocytopenic purpura resistant to steroids, immunosuppressants, and/or splenectomy in adults Milica C̆olović, Nada Suvajdžić, Nataša Čolović, Platelets	2010	32
Pretreatment risk factors and importance of comorbidity for overall survival, complete remission, and early death in patients with acute myeloid leukemia Irena Đjunić, Marijana Virijević, Aleksandra Novković, Hematology Mixed-phenotype Acute LeukemiaPrognosisLogistic AnalysisSerum Lactate DehydrogenaseMyeloid Neoplasia	2012	31
Intravascular large B-cell lymphoma as a cause of hypopituitarism: gradual and late reversal of hypopituitarism after long-term remission of lymphoma with immunochemotherapy Sandra Pekić, Slavica Milicevic, Nataša Čolović, Endocrine Lymphoid NeoplasiaLong-term RemissionHematologyLate ReversalPituitary Disease	2008	28

Page 1